cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Neurocrine Biosciences Inc
27 own
13 watching
Current Price
$146.5
$-0.62
(-0.42%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
9,167.92M
52-Week High
52-Week High
148.75000
52-Week Low
52-Week Low
94.16000
Average Volume
Average Volume
0.81M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
20.4735
iconMarket Capitalization9,167.92M
icon52-Week High148.75000
icon52-Week Low94.16000
iconAverage Volume0.81M
iconDividend Yield--
iconP/E Ratio20.4735
What does the Neurocrine Biosciences Inc do?
Neurocrine Biosciences, Inc. discovers and develops pharmaceuticals for the treatment of neurological and endocrine-related diseases and disorders in the United States and internationally. The company's lead products include INGREZZA (valbenazine), a vesicular monoamine transporter 2 inhibitor (VMAT2) used for the treatment of movement disorders; elagolix, a gonadotropin-releasing hormone (GnRH) antagonist that is in Phase III clinical trials used for women's health; and opicapone, a catechol-O-methyltransferase inhibitor, which is in Phase III clinical trials used for in adjunct therapy and preparations of levodopa/DOPA decarboxylase inhibitors for adult patients with Parkinson's disease. It is also developing NBI-640756 that is in Phase I clinical trials used for the treatment of essential tremor; and NBI-74788, which is in Phase I clinical trials used for the treatment of classic congenital adrenal hyperplasia. In addition, the company's research programs comprise VMAT2 Inhibitors for movement disorders, bipolar disorders, and schizophrenia; and G Protein-Coupled Receptors and Ion Channels for epilepsy, essential tremor, pain, and other Indications. It has collaborations with AbbVie Inc. to develop and commercialize elagolix and GnRH antagonists for women's and men's health; Mitsubishi Tanabe Pharma Corporation to develop and commercialize INGREZZA for movement disorders; and BIAL Portela & Ca, S.A. to develop and commercialize opicapone for the treatment of human diseases and conditions, including Parkinson's disease. Neurocrine Biosciences, Inc. was founded in 1992 and is headquartered in San Diego, California.
Read More
How much money does Neurocrine Biosciences Inc make?
News & Events about Neurocrine Biosciences Inc.
PR Newswire
1 year ago
Neurocrine Biosciences Supports the Mental Health Community During Tardive Dyskinesia Awareness Week Neurocrine Biosciences Supports the Mental Health Community During Tardive Dyskinesia Awareness Week PR Newswire SAN DIEGO, May 1, 2023 Approximately 600,000 people in the United States live with...
Ticker Report
1 year ago
Neurocrine Biosciences, Inc. (NASDAQ:NBIX Get Rating) insider Eiry Roberts sold 14,400 shares of the stock in a transaction dated Monday, April 24th. The shares were sold at an average price of $103.48, for a total transaction of $1,490,112.00. Following the completion of the transaction, ...
TipRanks Financial Blog
1 year ago
Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Cytokinetics (CYTK Research Report) and Neurocri... Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Cytokinetics (CYTK Research Report) and Neurocrine...
Benzinga
1 year ago
Latest Ratings for NBIX DateFirmActionFromTo Mar 2022Piper SandlerDowngradesOverweightNeutral Feb 2022Goldman SachsUpgradesNeutralBuy Feb 2022Morgan StanleyMaintainsEqual-Weight View More Analyst Ratings for NBIX View the Latest Analyst Ratings read more...
PR Newswire
1 year ago
Neurocrine Biosciences Presents Data on Improvements Over Time with Long-Term Use of INGREZZA (valbenazine) Capsules in Older and Elderly Patients at the American Association for Geriatric Psychiatry 2023 Annual Meeting Neurocrine Biosciences Presents Data on Improvements Over Time with Long-Term...
Frequently Asked Questions
Frequently Asked Questions
What is Neurocrine Biosciences Inc share price today?
plus_minus_icon
Can Indians buy Neurocrine Biosciences Inc shares?
plus_minus_icon
How can I buy Neurocrine Biosciences Inc shares from India?
plus_minus_icon
Can Fractional shares of Neurocrine Biosciences Inc be purchased?
plus_minus_icon
What are the documents required to start investing in Neurocrine Biosciences Inc stocks?
plus_minus_icon
What is today’s traded volume of Neurocrine Biosciences Inc?
plus_minus_icon
What is today’s market capitalisation of Neurocrine Biosciences Inc?
plus_minus_icon
What is the 52-Week High and Low Range of Neurocrine Biosciences Inc?
plus_minus_icon
What percentage is Neurocrine Biosciences Inc down from its 52-Week High?
plus_minus_icon
What percentage is Neurocrine Biosciences Inc up from its 52-Week Low?
plus_minus_icon
Current Price
$146.5
$-0.62
(-0.42%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Get Started with as little as $1.00